, Tracking Stock Market Picks
Enter Symbol:
The Medicines Company (MDCO) [hlAlert]

up 5.65 %

The Medicines Company (MDCO) upgraded to Buy by BofA/Merrill

Posted on: Thursday,  Aug 15, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy The Medicines Company (NASDAQ: MDCO) on 08/15/2013, when the stock price was $30.05. Since
then, The Medicines Company has gained 5.66% as of 01/15/2016's recent price of $31.75.
If you would have followed this BofA/Merrill's recommendation on MDCO, you would have gained 5.65% of your investment in 883 days.

The Medicines Company is a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The Company has two marketed products, Angiomax (bivalirudin) and Cleviprex (clevidipine butyrate) injectable emulsion, two products in late-stage development, cangrelor and oritavancin, which the Company acquired in February 2009, and one compound, CU-2010, scheduled to enter clinical development during 2009.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/15/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -3.42 %
1 Month down  -1.94 %
3 Months up  6.80 %
1 YTD up  22.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/22/2012 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy